Every announcement Alkem Laboratories has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Price
₹5161
Market Cap
₹61,707.50 Cr
Revenue TTM
₹15,081.28 Cr
P/E (TTM)
28.6×
Sector 48.54×
Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.
Alkem Laboratories Launches NeuCeno for Epilepsy; Targets 9.4 Million Patients in India
Alkem Laboratories launches NeuCeno (cenobamate) for partial-onset seizures in India, targeting 9.4 million patients with a once-daily anti-seizure m…
Alkem Laboratories Launches Renocia Exo Patented Hair Growth Serum in India
Alkem Laboratories launches Renocia Exo, India's first patented Ginsenoside Exosome-based hair serum, targeting the dermatology market. Market cap ₹6…
Alkem Laboratories Launches India's First Semaglutide Pre-Filled Syringes at ₹350
Alkem Laboratories launches India's first semaglutide single-shot pre-filled syringes starting at ₹350, expanding treatment for diabetes and obesity …
Track Alkem Laboratories in real time
ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Alkem Laboratories files something material.
Start Free — 15-day trial